ArticleOsteoarthritis imaging2024
3-dimensional bone shape and knee osteoarthritis: What have we learned?
Article in Osteoarthritis imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Transformative approaches for effective clinical trials to reduce the disease burden of osteoarthritis.Seminars in arthritis and rheumatism · 2025Review
- ShapeMed-Knee: A Dataset and Neural Shape Model Benchmark for Modeling 3D Femurs.IEEE transactions on medical imaging · 2025Article
- Editorial for the Special -Issue on Biomechanics and Imaging.Osteoarthritis imaging · 2025Article
- 3D bone shape from CT-scans provides an objective measure of osteoarthritis severity: Data from the IMI-APPROACH study.Osteoarthritis imaging · 2024Article
- ShapeMed-Knee: A Dataset and Neural Shape Model Benchmark for Modeling 3D Femurs.medRxiv : the preprint server for health sciences · 2024Article
Corrections and comments
- Erratum issued
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The concept that multiple joint tissues are involved in the osteoarthritis (OA) disease process is now widely accepted. There have been significant and important insights over the past two decades in the understanding of bone as a tissue undergoing pathological changes in OA. The specific bony changes of osteophyte growth and "bone attrition" associated with OA have been recognized for many years with several semi-quantitative radiographic and magnetic resonance imaging (MRI) grading systems designed to capture the magnitude of these changes. Over the past decade, there has been significant and important progress in the quantitative measurement of these changes. Manual methods for measuring bone area from 3D MR images have been improved with automation which offers both superior precision and a more responsive measurement that has been applied in several DMOAD randomized controlled trials. Measurement of true 3D bone shape, as opposed to simple geometric measures such as curvature and length, depends on automated methods of segmentation. In this field, important developments have taken place in the statistical parameterization of shape and the construction of OA vs non-OA shape metrics. Work has demonstrated that bone shape may provide an indication of OA status, may predict future OA onset, and is associated with clinical markers of OA such as pain, function and total joint replacement (TKR). Thus, bone shape may be a useful imaging biomarker for OA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.